Korean J Intern Med.  2018 Mar;33(2):256-276. 10.3904/kjim.2018.036.

Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea

Affiliations
  • 1Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. symonlee@catholic.ac.kr
  • 2The Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 3Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract

Hematopoietic stem cell transplantation (HSCT) is a treatment for hematologic malignancies, immune deficiencies, or genetic diseases, ect. Recently, the number of HSCTs performed in Korea has increased and the outcomes have improved. However, infectious complications account for most of the morbidity and mortality after HSCT. Post-HSCT infectious complications are usually classified according to the time after HSCT: pre-engraftment, immediate post-engraftment, and late post-engraftment period. In addition, the types and risk factors of infectious complications differ according to the stem cell source, donor type, conditioning intensity, region, prophylaxis strategy, and comorbidities, such as graft-versushost disease and invasive fungal infection. In this review, we summarize infectious complications after HSCT, focusing on the Korean perspectives.

Keyword

Hematopoietic stem cell transplantation; Immunocompromised host; Infectious diseases; Opportunistic infections

MeSH Terms

Communicable Diseases
Comorbidity
Hematologic Neoplasms
Hematopoietic Stem Cell Transplantation*
Hematopoietic Stem Cells*
Humans
Immunocompromised Host
Korea*
Mortality
Opportunistic Infections
Risk Factors
Stem Cells
Tissue Donors
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr